Company Overview
Herbalife Ltd. operates as a global provider of health and wellness products, distributing meal replacements, protein shakes, and drink mixes across North America, Latin America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company functions within the Consumer Defensive sector, specifically under the Packaged Foods industry, which typically implies a business model focused on essential or non-discretionary consumer goods that tend to exhibit lower price elasticity during economic downturns. As of the latest reporting period, the entity maintains a market capitalization of $1.52B and employs a workforce of 8,500 individuals to support its extensive distribution network. The combination of a $1.52B market cap and $5.04B in annual revenue indicates that while the company has achieved significant scale in generating top-line sales, its valuation relative to earnings suggests a specific market perspective on its future profitability and operational efficiency compared to larger peers in the consumer staples space.
Financial Health
Herbalife Ltd. reported total revenue of $5.04B over the trailing twelve months, with a corresponding net income of $228.30M and an EBITDA of $618.30M, highlighting a significant divergence between gross sales and final profit that underscores a substantial cost structure including cost of goods sold, operating expenses, and taxes. The company generated free cash flow of $247.69M, which provides a tangible measure of its financial flexibility to fund operations, repay debt, or invest in product development without relying solely on external financing. Profitability analysis reveals a gross margin of 77.9%, indicating high pricing power or efficient sourcing of ingredients, contrasted by an operating margin of 8.3% and a profit margin of 4.5%, suggesting that significant operating costs erode the gross profit before arriving at the bottom line. On the balance sheet, the company holds $353.10M in cash against $2.18B in total debt, a disparity that necessitates a closer look at liquidity management given the return on equity is listed as N/A, though the return on assets stands at 11.3%. The current ratio is recorded at 1.13, indicating that for every dollar of current liabilities, the company holds just over one dollar in current assets, which points to a relatively tight but manageable short-term liquidity position. While the debt-to-equity ratio is listed as N/A, the presence of substantial debt relative to cash reserves suggests a leveraged balance sheet that relies on consistent cash flow generation to meet obligations. The return on assets metric of 11.3% demonstrates that management is utilizing the company's asset base effectively to generate earnings, even as the return on equity remains unavailable in the current dataset.
Valuation Assessment
The valuation metrics for Herbalife Ltd. show a trailing twelve-month P/E ratio of 6.66 compared to a forward P/E of 4.80, implying that the market expects a reduction in the P/E multiple over the coming year, potentially driven by anticipated changes in earnings per share or a shift in risk premiums. The price-to-book ratio is reported as -2.94, a negative figure that technically indicates the company's book value is negative or that the accounting structure presents book value as a liability, which renders the traditional concept of a premium or discount over book value inapplicable in a standard sense. Alternative valuation measures such as the price-to-sales ratio of 0.30 and an EV/EBITDA of 5.42 suggest the stock is priced at a fraction of its revenue and enterprise earnings, often seen in capital-intensive businesses or those undergoing significant restructuring. In terms of trading range, the stock has fluctuated between a 52-week high of $20.40 and a 52-week low of $6.20, meaning the current price sits significantly below the recent peak, reflecting recent market corrections or sentiment shifts. The beta value of 0.85 indicates that the stock's price volatility is lower than the broader market, suggesting it may be less sensitive to general market swings than the average stock.
Growth & Income
The company's growth profile is characterized by a revenue growth rate of 6.3% year-over-year, while earnings growth declined by -53.3% year-over-year, revealing a scenario where top-line sales expansion is not being translated into proportional profit growth. This divergence implies that the cost structure or one-time expenses have weighed heavily on earnings despite the continued increase in sales volume. As a non-dividend payer, Herbalife does not distribute a dividend yield or utilizes a payout ratio, as both are listed as N/A and 0.0% respectively, indicating that the company retains all earnings for reinvestment into operations, debt reduction, or future growth initiatives rather than returning capital to shareholders. The overall growth and income profile presents a mixed picture where revenue stability offers some defensive characteristics, but the sharp contraction in earnings growth and the absence of dividend payouts suggest that shareholder returns are currently being generated solely through potential capital appreciation rather than income distributions.